Atea-Roche plans for Covid pill hit by poor trial results

ZURICH, Switzerland (AFP) — US-based Atea Pharmaceuticals said Tuesday its plans to develop an orally administered drug to treat coronavirus patients together with Swiss pharma giant Roche have suffered a set back in clinical trials. The drug “did not meet its primary endpoint, showing no significant reduction in viral load,” Atea said in a statement. When compared to a placebo administered to some of the hospitalised patients in the trial “no meaningful difference was seen […]